Introduction The prevalence of osteoporosis and fragility fractures increases sharply with age, yet diagnosis in the “oldest old” (≥85 years) remains inconsistent and often delayed. This age group experiences the highest fracture-related morbidity and mortality but is underrepresented in both screening programs and clinical trials (1). Standard dia